SuperworthBiomerica market cap BMRA
Share price times shares outstanding: what the whole company sells for, since 2012.
- Today, Oct 23, 2026
- $7.7M
- Highest close in our data
- $123.9M
- Jul 2020
Biomerica is worth $7.7M at the close on Oct 23, 2026, at $1.68 a share.
That is down 9% over the last year and down 87% over five years.
Its highest close in our data was $123.9M in Jul 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $7.7M | $4.6M | $11.5M | −0% |
| 2025 | $7.7M | $5.7M | $15.4M | +46% |
| 2024 | $5.3M | $4.6M | $21.7M | −75% |
| 2023 | $21M | $12.5M | $45.1M | −53% |
| 2022 | $45M | $35.3M | $59.6M | −8% |
| 2021 | $48.7M | $43.7M | $92.6M | −17% |
| 2020 | $58.5M | $25.2M | $123.9M | +121% |
| 2019 | $26.5M | $17.7M | $33.5M | +64% |
| 2018 | $16.2M | $16.2M | $42.2M | −49% |
| 2017 | $31.9M | $16.9M | $35M | +69% |
| 2016 | $18.8M | $8.5M | $24.5M | +92% |
| 2015 | $9.8M | $5.6M | $9.8M | +44% |
| 2014 | $6.8M | $5.2M | $7.6M | +18% |
| 2013 | $5.8M | $5.8M | $8.4M | −2% |
| 2012 | $5.9M | $4.5M | $5.9M | n/a |
Against its peers
Companies in Healthcare nearest Biomerica's size, closest first, today.
| Company | Market cap |
|---|---|
| BMRABiomerica | $7.7M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $56.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Biomerica
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.